WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Serious about science: Serious about timing
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (24)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simen, A. A.
Right arrow Articles by Miller, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simen, A. A.
Right arrow Articles by Miller, R. J.

 Previous Article  |  Next Article 

The Journal of Neuroscience, October 1, 2001, 21(19):7587-7597

The C Terminus of the Ca Channel alpha 1B Subunit Mediates Selective Inhibition by G-Protein-Coupled Receptors

Arthur A. Simen, Chong C. Lee, Birgitte B. Simen, Vytautas P. Bindokas, and Richard J. Miller

Department of Neurobiology, Pharmacology, and Physiology, University of Chicago, Chicago, Illinois 60637


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Inhibition of calcium channels by G-protein-coupled receptors depends on the nature of the Galpha subunit, although the Gbeta gamma complex is thought to be responsible for channel inhibition. Ca currents in hypothalamic neurons and N-type calcium channels expressed in HEK-293 cells showed robust inhibition by Gi/Go-coupled galanin receptors (GalR1), but not by Gq-coupled galanin receptors (GalR2). However, deletions in the C terminus of alpha 1B-1 produced Ca channels that were inhibited after activation of both GalR1 and GalR2. Inhibition of protein kinase C (PKC) also revealed Ca current modulation by GalR2. Imaging studies using green fluorescent protein fusions of the C terminus of alpha 1B demonstrated that activation of the GalR2 receptor caused translocation of the C terminus of alpha 1B-1 to the membrane and co-localization with Galpha q and PKC. Similar translocation was not seen with a C-terminal truncated splice variant, alpha 1B-2. Immunoprecipitation experiments demonstrated that Galpha q interacts directly with the C terminus of the alpha 1B subunit. These results are consistent with a model in which local activation of PKC by channel-associated Galpha q blocks modulation of the channel by Gbeta gamma released by Gq-coupled receptors.

Key words: Ca channels; G-proteins; Galpha q; C terminus; galanin; G-protein receptors; PKC


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Activation of G-protein-coupled receptors (GPCRs) is one of the major ways in which neurons respond to external signals. Activation of many GPCRs results in the inhibition of voltage-dependent Ca channels. The resulting reduction in Ca influx is a major mechanism by which neurons regulate the release of neurotransmitters (Miller, 1998). Activation of GPCRs produces several different types of Ca channel inhibition. The best studied of these processes is characterized by a slowing of Ca channel activation and is voltage-dependent, the inhibition being relieved by a depolarizing prepulse (Bean, 1989; Hille, 1994). It is thought that this type of inhibition is effected through the direct interaction of G-protein beta gamma subunits with the pore-forming alpha 1 subunit of the Ca channel (Herlitze et al., 1996; Ikeda, 1996; De Waard et al., 1997). Interaction of beta gamma subunits with the I/II loop and C terminus of the alpha 1 subunit has been demonstrated, although other regions of the channel appear to be involved, including the N terminus and domain I (Zhang et al., 1996; Zamponi et al., 1997; Page et al., 1998; Simen and Miller, 1998, 2000; Stephens et al., 1998). This mechanism of Ca channel inhibition has been described as "membrane-delimited," because it does not appear to involve freely diffusible intermediates. It is interesting to note, however, that the activation of GPCRs does not always produce voltage-dependent inhibition of Ca channels (Bernheim et al., 1991; Taussig et al., 1992; Shapiro and Hille, 1993; Shapiro et al., 1994; Liu et al., 1995; Margeta-Mitrovic et al., 1997).

According to the above discussion, one would expect that the productive activation of any GPCR would result in Ca channel inhibition by virtue of the fact that Gbeta gamma subunits are released. However, Ca channel inhibition appears to depend on the nature of the Galpha molecule with which a receptor is coupled. Activation of Galpha i/Galpha o-coupled (Dolphin and Scott, 1987; Ikeda and Schofield, 1989), Galpha z-coupled (Jeong and Ikeda, 1998), and Galpha s-coupled (Hille, 1994) receptors generally causes voltage-dependent inhibition of Ca channels, but the activation of receptors coupled to other Galpha subunits (e.g., Galpha q/11) usually does not (Shapiro and Hille, 1993; Hille, 1994; Shapiro et al., 1994). On the other hand, activation of Galpha q/11-linked receptors often produces a slow, voltage-independent inhibition of Ca channels, the mechanism of which has not been determined. Recently, for example, it has been demonstrated that Galpha q mediates voltage-independent inhibition of Ca channels produced by M1 muscarinic receptors (Haley et al., 2000), whereas activation of M2 receptors produces pertussis toxin-sensitive voltage-dependent inhibition (Toselli et al., 1995).

We have tried to determine why activation of some GPCRs fails to produce voltage-dependent Ca channel inhibition. Here we show that the differential susceptibility of N-type Ca channels to Galpha i/Galpha o- versus Galpha q-coupled galanin receptors depends on structural elements in the C terminus of the Ca channel alpha 1 subunit and provide evidence that protein kinase C (PKC) may play an important role in mediating these effects.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Acute isolation of hypothalamic neurons. Acutely isolated neurons from the hypothalamus were obtained from rat pups 10-16 d old. Rat pups were anesthetized and decapitated. The hypothalamus was rapidly removed and chilled to 4°C by submerging it in 4°C Ringer's solution (in mM: 126 NaCl, 26.2 NaHCO3, 1.0 NaH2PO4, 3.0 KCl, 1.5 MgSO4, 2.5 CaCl2, and 10 glucose) while bubbling with 95% O2 and 5% CO2. The tissue was mounted in a vibratome (TPI), and 400 µm cuts were made though the hypothalamus containing the arcuate nucleus. The brain slices were transferred to a holding chamber containing Ringer's solution at 35°C for 1 hr. Tissues were then enzymatically treated with papain (15 U/ml; Roche Molecular Biochemicals, Indianapolis, IN) for 1 hr. Papain was then inactivated by treating the tissue with ovomucoid. Brain slices were returned to the holding chamber until needed.

Neurons from the arcuate nucleus of the hypothalamus were isolated by micropunching the area just lateral to the third ventricle. Neurons were dissociated by gentle mechanical trituration using multiple pipettes of decreasing bore diameters. Cells were then plated onto glass coverslips precoated with poly-L-lysine. Cells were placed into a 35°C incubator and allowed to settle for a minimum of 30 min before electrophysiological recordings were made.

Receptor and alpha 1 subunit plasmid preparation. Rat galanin receptors 1 and 2 (GalR1 and GalR2) were cloned from a rat hypothalamic cDNA library (Clontech, Cambridge, UK) using PCR. Forward and reverse primers were designed from the reported sequences for GalR1 and GalR2 (GenBank accession numbers, U30290 and AF010318). The PCR products were isolated and subcloned into pGemT-Easy (Promega, Madison, WI). Multiple clones were sequenced with dRhodamine terminator cycle sequencing mix (PerkinElmer Life Sciences, Emeryville, CA) and an automated DNA sequencer (ABI 377; PerkinElmer Life Sciences). Error-free clones were selected and subcloned into a mammalian expression vector, pcDNA 3.1 (Invitrogen, San Diego, CA) or a modified pIRES-EYFP vector (Clontech).

Calcium channel subunit cDNAs encoding alpha 1B-1, alpha 1B-2, alpha 2/delta , and beta 1b were kindly provided by SIBIA Neurosciences. cDNAs encoding the various wild-type G-protein alpha  subunits (Galpha i1, Galpha o, and Galpha q) and constitutively activated G-protein alpha  subunits (Q-to-L mutations to eliminate GTPase activity: Galpha i1Q240L, Galpha oQ250L, and Galpha qQ209L) were provided by Ronald Taussig (University of Michigan). cDNA for the kappa -opioid receptor (kappa OR) was kindly provided by Dr. Graeme I. Bell (Howard Hughes Medical Institute, University of Chicago).

Modifications in the C terminus of alpha 1B-1 were described previously (Simen and Miller, 2000). The Delta 1875-2339 construct was created by deleting the nucleotides coding for amino acids (aa) 1875-2339 and adding a stop codon to the construct. The construct Delta 2037-2087 is a deletion of aa 2037-2087. The Delta 2037-2087 construct was created by replacing the nucleotides coding for residues 2037-2087 with a HindIII site, which codes for the amino acids Arg and Leu. Each of the C-terminal constructs was verified by DNA sequencing.

Transfections. Monolayers (<80% confluence) of HEK-293 or tsA-201 cells were replated on the day of transfection. Plasmids were transfected using Fugene 6 (Roche Molecular Biochemicals) per the manufacturer's instructions or polyethyleneimine as previously described (Simen and Miller, 1998). Twenty-four to 48 hr after transfection, cells were replated onto glass coverslips precoated with poly-L-lysine. Calcium currents were recorded 36-72 hr after transfection from CD8-positive or green fluorescence protein (GFP)-positive cells. CD8-transfected cells were labeled with a 1:1000 dilution of microspheres coated with an antibody against the CD8alpha antigen (Dynal, Oslo, Norway).

Electrophysiological recordings. Total Ba2+ currents were measured using the tight-seal whole-cell patch-clamp technique. The coverslips were mounted in a perfusion chamber and constantly perfused by a gravity feed system with a modified HEPES-balanced salt solution (in mM: 5 BaCl2, 143 tetraethylammonium chloride, 1 MgCl2, 10 Hepes, and 10 glucose, pH adjusted to 7.4 and osmolarity to 310 mOsm) to isolate the Ba2+ current. Patch pipettes of 2-6 MOmega resistance were filled with a solution containing 135 mM CsCl, 1 mM MgCl2, 10 mM HEPES, 10 mM BAPTA, 14 mM phosphocreatine, 3.6 mM MgATP, 3.6 mM LiGTP, and 50 U/ml creatine phosphokinase, adjusted to pH 7.3 with CsOH and 290 mOsm. Data were digitized at 10 kHz and filtered at 2 or 5 kHz. Series resistance was compensated >= 70%, and currents were leak-corrected on-line using a P/5 protocol (Armstrong and Bezanilla, 1977).

Currents were measured and recorded with an Axopatch 200B (Axon Instruments) or EPC9 (Heka) amplifier using the Clampex program (pClamp 6 software suite; Axon Instruments) or the Pulse program (Heka). All experiments and solutions were used at room temperature. Each coverslip was used only once to prevent any possible effects of desensitization. However, no evidence of desensitization from multiple applications of galanin and its analogs was observed.

Unless otherwise noted, statistical analyses were performed using the Kruskal-Wallis variant of the ANOVA test followed by Dunn's post hoc test.

Measurement of [Ca]i with fura-2. After isolating neurons as described above, cells were loaded with fura-2 methyl-ester (Molecular Probes, Eugene, OR; 3 µM fura-2 for 20 min at room temperature). Cells were then washed with a HEPES-balanced salt solution (in mM: 140 NaCl, 10 HEPES, 2 CaCl2, 2 MgCl2, 5 KCl, and 10 glucose, pH 7.4 and adjusted to ~310 mOsm.) for 20 min to allow for deesterification of Fura-2. Changes in free internal calcium concentration ([Ca]i) were monitored using digital video microfluorimetry. An intensified CCD camera (Hamamatsu, Hamamatsu City, Japan) coupled to a Nikon (Mellville, NY) Diaphot microscope and Metafluor software (Universal Imaging Corp., West Chester, PA) was used to gather intensity values. Cells were excited at 340 and 380 nm using a 150 W Xe arc and computer-controlled filter wheel. Ratio intensities were calibrated via an eight point curve derived from imaging droplets of 50 µM fura-2 in calibrated free calcium buffers (Molecular Probes). Ratio intensities and calculated calcium concentrations from marked areas of interest were logged to a computer. Drugs were bath-applied using a gravity feed system at room temperature.

Fusion constructs. Fragments of the C terminus were expressed as fusion proteins with GFP. The GFP-C1 construct consisted of GFP fused to aa 1768-2339 of the human alpha 1B-1 Ca channel. The GFP-C2 construct consisted of GFP fused to aa 1768-2237 of the alpha 1B-2 Ca channel. The GFP-CC1 construct consisted of GFP fused to aa 1871-2339 of alpha 1B-1. The GFP-CC2 construct consisted of GFP fused to aa 1871-2237 of alpha 1B-2. The GFP-CCC1 construct consisted of aa 2164-2339 of alpha 1B-1 fused to GFP. The GFP-N construct consisted of aa 1768-2109 of alpha 1B-1 fused to GFP. The GFP-NN construct consisted of aa 1768-2009 of alpha 1B-1 fused to GFP. The GFP-NNN construct consisted of aa 1768-1875 alpha 1B-1 fused to GFP. Each of these constructs was constructed by ligating the appropriate fragment into the XhoI and XbaI sites of the pEYCP-C1 vector (Clontech).

Immunoprecipitation experiments. tsA-201 cells were transfected with GFP-C1, GFP-C2, GFP-CC1, GFP-CC2, or GFP-CCC1 in combination with rat Galpha q, rat Galpha q*, rat GalR2, or rat µOR. Two to 3 d after transfection, cells were washed once and dissociated for 10 min in 2 ml of PBS. Cells were then centrifuged at 800 rpm for 8 min at 4°C in flat-sided 10 ml tubes. The cells were then resuspended in 500 µl of labeling medium devoid of methionine and cysteine (Life Technologies, Gaithersburg, MD) and incubated for 20 min at 37°C. One hundred fifty microcuries of ProMix (300 µCi/ml; Amersham Pharmacia Biotech, Arlington Heights, IL) was then added, and cells were incubated at 37°C for 3 hr. The cells were then centrifuged at 800 rpm for 8 min at 4°C and resuspended in 200 µl of lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 20 mM iodacetamide, 5 mM KCl, 5 mM MgCl2, 1% IGEPAL CA-630, and 20 U/ml aprotinin), in addition to a protease inhibitor mixture (in µg/ml: 10 N-P-tosyl-L-arginine methyl ester, 10 tosyl-L-phenylalanine-chloromethyl ketone, 10 soybean trypsin inhibitor, 1 leupeptin, and 1 pepstatin A, final concentrations). The cells were lysed for 25 min on ice and centrifuged at 10,000 × g for 10 min at 4°C. Incorporation of radioactivity in total protein was determined as TCA-precipitable counts in duplicates of 1 µl of lysate and used to normalize input of lysates in immunoprecipitation experiments.

Samples were precleared by adding 60 µl of recombinant protein A coupled to Sepharose CL6 beads (Repligen) to the lysates. The samples were taken up to a total volume of 700 µl with TNNB (50 mM Tris, pH 8.0, 250 mM NaCl, 0.5% IGEPAL CA-630, 0.5 mM PMSF, 0.02% NaN3, 0.1% BSA, and protease inhibitor mixture). The reactions were mixed on a rotator for 1 hr at 4°C and were then centrifuged, and the supernatants were mixed overnight at 4°C with fresh protein A-Sepharose and the appropriate antibody. Two microliters of rabbit anti-Galpha q antiserum (Calbiochem, La Jolla, CA), 5 µl of rabbit anti-GFP (Molecular Probes), or 5 µl of rabbit anti-beta subunit antibody (Calbiochem) were used for immunoprecipitation. The protein A beads were washed three times with 1 ml of TNNB at 4°C and then three times with 1 ml of TNNB without BSA at 4°C. The proteins were then eluted with 80 µl of 1× reducing sample buffer by brief mixing and boiling for 3 min. Forty microliters of eluate were then loaded on 9 or 13% SDS-PAGE gels. The gels were run at 30 mA for ~4 hr, dried onto Whatman (Maidstone, UK) 3M paper for 1 hr at 80°C under vacuum, exposed to a low-energy PhosphorImager screen overnight (Molecular Dynamics, Sunnyvale, CA), and analyzed in a Storm 860 PhosphorImager (Molecular Dynamics).

Confocal imaging of staining patterns. Cells were fixed for 20 min with 4% paraformaldehyde 48-72 hr after transfection and mounted in 60% glycerol, 5% n-propyl gallate, and PBS, buffered to pH 7.8 with Tris. Some cells were permeabilized with Triton X-100 and treated with anti-Galpha primary antibody (Calbiochem) or anti-hemagglutinin (HA) primary antibody (Molecular Probes) for 1-12 hr. Staining of Galpha q and HA epitope-tagged PKC-delta was revealed by a Cy5-conjugated secondary antibody (Jackson ImmunoResearch, West Grove, PA) and Texas Red-conjugated secondary antibody (Covance), respectively. Slides were scanned on an Olympus Optical (Tokyo, Japan) Fluoview LSM confocal system typically using a 60×, numerical aperture 1.4 objective and excitation at 488 and 647 nm for GFP and Cy5, respectively. Emissions at 510-550 and 700-775 nm were collected on separate detectors. Optical sections were taken at 0.3 nm vertical steps throughout the entire cell volume. Staining controls (processed without primary antibody or nontransfected cells) were scanned under identical machine settings to verify that the fluorescence was specific. Cells with clumped GFP contents were excluded from analyses. Volume reconstructions were created in Metamorph version 4.5 (Universal Imaging). Fluorescence intensity maps were plotted for linear transects drawn through the cytosol at the equatorial plane.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Selective modulation of N-type channels by galanin receptors

An example of the selectivity of Ca channel regulation by GPCRs is afforded by comparison of the effects of activating two galanin receptors, GalR1 and GalR2. GalR1 exhibits low affinity for the GalR2 specific agonist [D-Trp2] galanin (Smith et al., 1997, 1998; Wang et al., 1997a,b, 1998). GalR1 and GalR2, unlike GalR3, have been shown to be highly expressed in the hypothalamus (Smith et al., 1997, 1998; Wang et al., 1997a,b, 1998). We therefore examined the effects of galanin and it analogues on Ba2+ currents in acutely isolated neurons from the arcuate nucleus of the hypothalamus. [D-Trp2] galanin was used to distinguish between the effects of the two receptors.

Figure 1a demonstrates that the application of multiple galanin receptor agonists, with the notable exception of [D-Trp2] galanin, inhibited the Ba2+ current in acutely isolated hypothalamic neurons (n = 13). This pharmacological profile suggests that activation of GalR1 receptors, but not GalR2 receptors, in these neurons is linked to inhibition of the Ba2+ current. The inhibition was voltage-dependent, being substantially relieved by a strong depolarizing prepulse to +80 mV (Fig. 1b, i). Although application of [D-Trp2] galanin did not produce any inhibition of the Ba2+ current (e.g., Fig. 1a), robust [Ca]i mobilization (n = 8; data not shown) was observed, as expected from the activation of a Galpha q-coupled receptor. Thus, activation of GalR1 but not GalR2 receptors in hypothalamic neurons produces voltage-dependent inhibition of the Ba2+ current. However, activation of GalR2 receptors mobilizes [Ca]i, consistent with previous expression studies (Smith et al., 1997, 1998).



View larger version (20K):
[in this window]
[in a new window]
 
Figure 1.   Effects of galanin analogs on acutely dissociated hypothalamic neurons and on HEK293 cells transiently transfected with GalR1 or GalR2 together with N-type Ca channel subunits (alpha 1B-1, alpha 2/delta , and beta 1b). a, Typical experiment on a hypothalamic neuron in which the Ba2+ current was inhibited by repeated application of different galanin analogs. All peptides were used at 100 nM. Peak Ba2+ currents expressed in picoamperes are plotted versus time expressed in minutes. The Ba2+ current was elicited every 20 sec from a holding potential of -80 mV to a test potential of +10 mV for 200 msec. a, i, ii, Corresponding currents at the times specified in the current plot. b, i, Representative hypothalamic neuron demonstrating prepulse facilitation of the Ba2+ current during an application of galanin. The plot is an overlay of two current traces during two separate voltage protocols, where the second trace (*) contains a voltage step to a positive potential of +80 mV interspersed between two test pulses. b, ii, Voltage protocols used to generate the currents in b, i. c, i, Typical experiment with an HEK293 cell expressing GalR1 and N-type Ca channels. The Ba2+ current was inhibited by application of galanin but not [D-Trp2] galanin. Galanin and [D-Trp2] galanin were used at 100 nM. The Ba2+ current was elicited using the same protocol in a. c, ii, Representative GalR1-expressing HEK cell demonstrating prepulse facilitation of the Ba2+ current during an application of galanin. The plot is an overlay of two current traces during two separate voltage protocols in which the second trace (*) contains a voltage step to a positive potential of +80 mV interspersed between two test pulses. The voltage protocols used are identical to the one illustrated in b, ii. d, Typical experiment with a HEK293 cell expressing GalR2, kappa OR, and N-type Ca channels. The peak Ba2+ current was not inhibited by application of galanin (100 nM) but was inhibited by the application of the kappa OR agonist U69593 (1 µM). The Ba2+ current was elicited using the same protocol in a.

Similar results were obtained with cloned rat galanin receptors (GalR1 and GalR2) expressed in HEK-293 cells together with the N-type Ca channel subunits alpha 1B-1, alpha 2/delta , and beta 1B. As with the hypothalamic neurons, GalR1-expressing HEK cells showed a large voltage-dependent inhibition of the Ba2+ current on application of galanin or galanin agonists (Fig. 1c). Galanin and its analogs ([1-16] galanin, M15, M32, M40, and C7) blocked the Ba2+ current by 73.00 ± 2.70% (n = 8), 61 ± 1.70% (n = 6), 63 ± 1.90% (n = 5), 65 ± 3.70% (n = 7), 62 ± 2.90% (n = 5), and 81 ± 5.90% (n = 5), respectively. Application of [D-Trp2] galanin had no effect on the Ba2+ current in GalR1-expressing cells (Fig. 1c). When GalR2 receptors were expressed in HEK cells together with N-type Ca channels, neither application of galanin (n = 9; data not shown) nor [D-Trp2] galanin (n = 7; Fig. 1d) produced inhibition of the Ba2+ current, even though activation of Gi/Go-coupled kappa ORs expressed in the same cells by the kappa OR selective agonist U69593 was clearly effective (Fig. 1d). Overnight pretreatment with pertussis toxin (PTX) completely blocked inhibition of N-type currents by galanin (n = 6; data not shown), suggesting that GalR1 preferentially couples to Galpha i, Galpha o, or both.

Mobilization of [Ca]i was examined in HEK cells transfected with either GalR1 or GalR2. In cells expressing GalR1, application of galanin (n = 15) or [D-Trp2] galanin (n = 15) did not increase [Ca]i (data not shown). However, application of carbachol to activate endogenous muscarinic receptors produced [Ca]i mobilization, and this effect could be blocked by treating the cells with thapsigargin (data not shown). In contrast, HEK cells transfected with GalR2 showed large increases in [Ca]i after application of [D-Trp2] galanin and other galanin analogs (data not shown). The mobilization of [Ca]i after GalR2 activation was blocked by pretreating the cells with thapsigargin (data not shown; n = 12), suggesting that the source of Ca was from thapsigargin-sensitive internal stores. Overnight incubation with PTX did not block the ability of either galanin (n = 16) or [D-Trp2] galanin (n = 8; data not shown) to increase [Ca]i in GalR2-expressing cells, suggesting that GalR2 preferentially couples to a PTX-insensitive G-protein such as Galpha q or Galpha i1.

Selectivity of Ca channel inhibition depends on structural elements in the C terminus of the alpha 1 subunit

Although activation of GalR2 receptors produced no inhibition of wild-type alpha 1B-1 Ca channels, we found that certain modifications to the C terminus of the channel alpha 1 subunit rendered it susceptible to inhibition. We compared wild-type alpha 1B-1 with two C-terminal mutations of alpha 1B-1. The first C-terminal change we examined was a truncation of alpha 1B-1 (Delta 1875-2339). This C-terminal truncation includes a region previously implicated in interactions with Galpha i (Furukawa et al., 1998a,b). The second modified channel we expressed was Delta 2037-2087, containing a deletion encompassing a region in alpha 1B-1 homologous to a putative Gbeta gamma binding site previously described in the C terminus of alpha 1E (Qin et al., 1997). We have previously shown that these C-terminal alterations have little to no effect on the ability of a Gi/Go-coupled receptor (kappa OR) to modulate the channel (Simen and Miller, 2000). Therefore, we used kappa OR in these studies as a positive control.

As expected, activation of kappa OR with U69593 (1 µM) produced voltage-dependent inhibition of Ba2+ currents in cells expressing wild-type alpha 1B-1, GalR2, and kappa OR (51 ± 3.4% inhibition; n = 6), whereas [D-Trp2] galanin (100 nM) had no significant effect (2.2 ± 0.5% inhibition; n = 6; Fig. 1d). kappa OR activation by U69593 also inhibited the Ba2+ current in cells expressing Delta 1875-2339 or Delta 2037-2087 in a voltage-dependent manner, similar to its effects on wild-type Ca channels (Fig. 2a-c). However, in contrast to wild-type alpha 1B-1, activating GalR2 with galanin (10-100 nM) elicited a robust inhibition of the Ba2+ current in Delta 1875-2339-expressing cells (Fig. 2a) and Delta 2037-2087-expressing cells (Fig. 2b). The magnitude of the inhibition of Delta 1875-2339 and Delta 2037-2087 seen after GalR2 activation was consistently smaller than that observed with kappa OR activation (Fig. 2a,b). U69593 blocked the Ba2+ current by 52 ± 5% (n = 6) and 55 ± 2% (n = 6) in Delta 1875-2339- and Delta 2037-2087-expressing cells, respectively, whereas galanin blocked the Ba2+ current by 30 ± 3.2% (n = 9) and 27 ± 2% (n = 6) in Delta 1875-2339- and Delta 2037-2087-expressing cells, respectively. When larger truncations in the C terminus of alpha 1B-1 were made (construct Delta 1768-2339), no functional channel expression was obtained (data not shown).



View larger version (12K):
[in this window]
[in a new window]
 
Figure 2.   Effects of galanin analogs on HEK293 cells transiently transfected with GalR2 and kappa OR together with Delta 1875-2339, Delta 2037-2087, or alpha 1B-2. In all three instances, the Ba2+ current was inhibited by the application of galanin (100 nM) and U69593 (1 µM). The Ba2+ current was elicited using same protocol as in Figure 1a. a-c, Representative currents from HEK cells expressing Delta 1875-2339, Delta 2037-2087, or alpha 1B-2, respectively, showing robust inhibition by U69593 as well as galanin. d, i, ii, Representative traces from GalR2-, kappa OR-, and Delta 1875-2339-expressing HEK293 cells, demonstrating prepulse facilitation of the Ba2+ current during application of U69593 and galanin, respectively. The plot is an overlay of two current traces during two separate voltage protocols, where the second trace (*) contains a voltage step to a positive potential of +80 mV interspersed between two test pulses. The voltage protocols used are identical to those illustrated in Figure 1b, ii.

We also characterized the voltage dependence of the GalR2 inhibition of Delta 1875-2339 and Delta 2037-2087 currents using a prepulse protocol. The inhibition of the Ba2+ current by galanin was partially relieved by a prepulse to +80 mV (Fig. 2d). The ratio of postpulse to prepulse currents (P2:P1) was similar for U69593 and galanin in Delta 1875-2339-expressing cells, 1.6 ± 0.10 (n = 5) and 1.5 ± 0.10 (n = 4), respectively. For Delta 2037-2087 expressing cells, somewhat lower P2:P1 ratios were observed for U69593 and galanin, 1.4 ± 0.09 (n = 5) and 1.3 ± 0.06 (n = 6), respectively. Thus, it appears that modifications to the alpha 1B-1 C terminus render it susceptible to inhibition in a voltage-dependent manner by activation of GalR2 receptors, in a manner that is typically observed with G-protein Gbeta gamma subunits. These data strongly suggest that Gbeta gamma subunits released by GalR2 activation are capable of inhibiting alpha 1B-1 but that the C terminus is somehow involved in blocking these effects.

Interestingly, a C-terminal splice variant of the alpha 1B subunit of the Ca channel (alpha 1B-2) was previously described (Williams et al., 1992). alpha 1B-2 differs from alpha 1B-1 in that alpha 1B-2 is shorter (2237 vs 2339 nucleotides) than alpha 1B-1 and differs in its last 74 amino acids when compared with alpha 1B-1. However, there has been little functional description of the properties of alpha 1B-2. We expressed alpha 1B-2 and examined its modulation by GalR1, GalR2, and kappa OR. Expression of alpha 1B-2, alpha 2/delta , beta 1b, kappa OR, and GalR2 produced a Ba2+ current that was inhibited by kappa OR. Application of U69593 blocked the Ba2+ current (51 ± 7%; n = 7) to an extent similar to that seen with alpha 1B-1 (Fig. 2c). As with alpha 1B-1, inhibition of alpha 1B-2 was voltage-dependent (P2:P1, 1.5 ± 0.1; n = 4). However, in contrast to alpha 1B-1, alpha 1B-2 was also inhibited by the activation of GalR2. GalR2 inhibited alpha 1B-2 Ca currents by 27 ± 0.9% (n = 6; Fig. 2c). The modulation of alpha 1B-2 by GalR2 was voltage-dependent, because a strong depolarizing prepulse partially relieved the observed inhibition. The P2:P1 ratio for galanin was 1.5 ± 0.1 in alpha 1B-2-expressing cells (n = 4). Overall, the prepulse ratios (P2:P1) for Delta 1875-2339 and alpha 1B-2 are similar to the ratios we previously reported for kappa OR and alpha 1B-1 (1.7 ± 0.13; Simen and Miller, 1998). The ratios for Delta 2037-2087 are somewhat lower, suggesting a lower degree of voltage dependence of inhibition for this particular construct, which involved the smallest alteration to the C terminus that we tested.

We explored the role of Galpha subunits in these effects by overexpressing various wild-type and mutant Galpha q subunits. When we overexpressed wild-type Galpha i, Galpha o, and Galpha q, activation of GalR1 inhibited alpha 1B-1 Ca currents to an extent similar to that in the control situation (Fig. 3a, i, b). Galanin inhibited the Ba2+ current in the presence of overexpressed wild-type Galpha i by 68 ± 4.9% (n = 4), inhibited the Ba2+ current by 71 ± 3.7% (n = 6) with Galpha o, and inhibited the Ba2+ current by 56 ± 5.9% (n = 10) with Galpha q (Fig. 3b). Overexpression of constitutively active Galpha i (Galpha i*) or Galpha o (Galpha o*) reduced the inhibition produced by GalR1 when compared with overexpression of wild-type Galpha i or Galpha o but to a lesser extent than Galpha q*. When we overexpressed Galpha i*, galanin inhibited the Ba2+ current by 33 ± 2.3% (n = 8), and in the presence of Galpha o*, galanin inhibited the Ba2+ current by 35 ± 4.1% (n = 6; Fig. 3b). In contrast, overexpression of constitutively active Galpha q (Galpha q*) potently blocked the ability of GalR1 to inhibit the Ba2+ current (Fig. 3a, ii, b). Activation of GalR1 inhibited wild-type Ca currents by 6.4 ± 2.5% (n = 12) when Galpha q* was overexpressed (Fig. 3b). Overall, overexpression of Galpha i or Galpha o yielded similar inhibition than overexpression of Galpha q (p > 0.05, Bonferroni corrected t test). However, overexpression of Galpha i* and Galpha o* allowed for significantly more inhibition than Galpha q* (p < 0.001; Bonferroni corrected t test). Therefore, overexpression of all three constitutively active Galpha species reduced inhibition to some extent, but Galpha q* was significantly more effective than Galpha i* or Galpha o* in blocking inhibition.



View larger version (13K):
[in this window]
[in a new window]
 
Figure 3.   Effects of expression of different wild-type and constitutively active G-protein alpha  subunits (denoted as Galpha *) on the ability of GalR1 to inhibit the Ba2+ current. a, Typical experiment illustrating an HEK293 cell expressing GalR1 and alpha 1B-1 with either Galpha q or Galpha q*. a, i, Currents from a typical cell expressing wild-type Galpha q, in which the Ba2+ current was inhibited by application of galanin (100 nM). a, ii, Typical cell expressing Galpha q* in which the application of galanin no longer inhibited the Ba2+ current. The Ba2+ current was elicited with the same protocol as in Figure 1a. b, Summary graph of the inhibitory effects of galanin on the Ba2+ current in HEK293 cells transfected with Galpha i, Galpha o, Galpha q, Galpha i*, Galpha o*, and Galpha q*. Data are expressed as percent inhibition of the peak Ba2+ current after the application of galanin (100 nM). Data are plotted as mean ± SEM. The number of responding cells in each group is in parentheses.

We tested the hypothesis that the actions of Galpha q were mediated through the C terminus of the Ca channel by overexpressing Galpha q* with either Delta 1875-2339 or alpha 1B-2 Ca channels to see whether it would inhibit GalR1 modulation as it did with alpha 1B-1. In contrast to its effects on alpha 1B-1, overexpression of Galpha q* was unable to block the GalR1 mediated inhibition of either Delta 1875-2339 or alpha 1B-2. Galanin inhibited the Ba2+ current in Delta 1875-2339- and Galpha q*-expressing cells by 28 ± 1.9% (n = 6) and by 34 ± 4.8% (n = 6) in alpha 1B-2- and Galpha q*-expressing cells. This should be compared with the inability of GalR1 to inhibit alpha 1B-1 in cells overexpressing Galpha q* (Fig. 3b). These results strongly suggest that the inhibitory actions of Galpha q are mediated in some manner by the C terminus of the channel.

GalR2 activation causes translocation of GFP-tagged C-terminal fragments of alpha 1B

The above results suggest that activation of GalR2 is ineffective in inhibiting alpha 1B-1 Ca channels by a mechanism involving Galpha q and the C terminus of the channel. However our results clearly suggest that even though alpha 1B-1 Ca channel inhibition is not observed after GalR2 activation, activation of the receptor might influence the state of the channel in a Galpha q-dependent manner. To demonstrate that activation of GalR2 does influence the alpha 1B-1 Ca channel, the cellular localization of various C-terminal fragments of alpha 1B-1 fused to GFP was determined by confocal fluorescence imaging before and after the activation of GalR2. The C terminus of alpha 1B-1 fused to GFP (GFP-C1; aa 1768-2339) was found to be distributed throughout the cytoplasm in untreated tsA-201 cells but translocated to the plasma membrane and co-localized with immunohistochemically localized Galpha q after stimulation of GalR2 (Fig. 4a,b). In contrast, the C terminus of alpha 1B-2 fused to GFP (GFP-C2; aa 1768-2237) and the GFP protein alone did not translocate to the plasma membrane after stimulation with galanin (Fig. 4c,d,f). In addition, when cells were transfected with the Gi/Go-coupled µOR rather than GalR2, no translocation was noted after receptor activation with the µOR selective agonist [D-Ala2,N-Me-Phe4, Gly5-ol]-enkephalin (DAMGO) (Fig. 4e), suggesting that translocation of C1-GFP is Galpha q-specific.



View larger version (72K):
[in this window]
[in a new window]
 
Figure 4.   The influence of GalR2 receptor activation on the localization of C terminal fragments of alpha 1B. tsA-201 cells were transfected with GFP-C1, GFP-C2, or a vector expressing the GFP protein alone, GalR2 or µOR, Galpha q, or Galpha i and were then immunostained with an anti-Galpha q antibody and a Cy5-conjugated secondary antibody. Data were obtained from two to five separate transfections in each case. a, In the absence of galanin (a, i), GFP-C1 as well as Galpha q were seen to be randomly distributed throughout the cytoplasm (n = 24 cells examined). After the application of galanin (a, ii), both Galpha q and GFP-C1 were seen to translocate to the plasma membrane (n = 30 cells examined). b, Left, Line scan of GFP fluorescence through a cell expressing C1-GFP and GalR2 without galanin application. b, Right, Line scan of GFP fluorescence through a cell expressing C1-GFP and GalR2 with galanin application. Note the enhancement near the plasma membrane (arrows). c, In the absence or presence of galanin, GFP-C2 as well as Galpha q were seen to be randomly distributed throughout the cytoplasm. d, Left, Line scan of GFP fluorescence through a cell expressing C2-GFP and GalR2 without galanin application (n = 8 cells examined). d, Right, Line scan of GFP fluorescence through a cell expressing C2-GFP and GalR2 with galanin application. Note the lack of enhancement near the plasma membrane (arrows; n = 24 cells examined). e, Left, Line scan of GFP fluorescence through a cell expressing C1-GFP, µOR, and Galpha i without DAMGO application (n = 11 cells examined). e, Right, Line scan of GFP fluorescence through a cell expressing C1-GFP, µOR, and Galpha i with DAMGO application (n = 17 cells examined). f, Left, Line scan of GFP fluorescence through a cell expressing GFP and GalR2 without galanin application (n = 10 cells examined). f, Right, Line scan of GFP fluorescence through a cell expressing GFP and GalR2 with galanin application (n = 9 cells examined). YFP, Yellow-shifted GFP.

Immunostaining with an antibody against rat Galpha q that does not recognize endogenous human Galpha q demonstrated that, after receptor activation, Galpha q was localized principally at the membrane and co-localized with GFP-C1 but not with GFP-C2 (Fig. 4a, ii, c). Translocation of these C-terminal fragments to the membrane and co-localization with immunohistochemically localized Galpha q therefore correlate with the sensitivity of alpha 1B-1 and alpha 1B-2 to occlusion of G-protein modulation by Galpha q. Although the C terminus is not free to undergo such translocation in the intact channel, our data suggest that the C terminus of alpha 1B-1 may be tethered to the membrane proximally by virtue of its connection to transmembrane domain IV of the channel as well as distally by virtue of a Galpha q-dependent mechanism. alpha 1B-2 may on the other hand be tethered to the membrane only proximally. These differences in arrangement with respect to the membrane may have important implications for signaling (discussed below).

Maximov et al. (1999) have shown that the C-terminal end of the alpha 1B-1 but not the alpha 1B-2 C terminus contains a PDZ interacting domain that interacts with the PDZ domain of Mint-1 in neurons. To test the hypothesis that such interactions are responsible for the differential interaction of alpha 1B-1 and alpha 1B-2 with the membrane after receptor activation, we attempted to amplify Mint-1 from HEK-293 cells by reverse transcription-PCR but were unable to do so, although human fetal brain yielded robust PCR products (data not shown), consistent with a primarily neuronal distribution of expression as previously described (Okamoto and Sudhof, 1997). In addition, overexpression of the PDZ domain of human Mint-1 failed to alter the cellular distribution of the C1-GFP molecule before or after GalR2 activation by galanin (data not shown).

Galpha q binds directly to the C terminus of alpha 1B

In an attempt to understand how Galpha q influences the channel in a manner that depends on the C terminus, we sought to determine whether Galpha q interacts directly with the C terminus of alpha 1B. Galpha q* and various alpha 1B C-terminal fragments fused to GFP were co-expressed in tsA-201 cells, and immunoprecipitation experiments were performed (Fig. 5). These fragments included GFP-Cl, GFP-C2, aa 1871-2339 of alpha 1B-1 (GFP-CC1), aa 1871-2237 of alpha 1B-2 (GFP-CC2), aa 2164-2339 of alpha 1B-1 (GFP-CCC1), aa 1768-2109 of alpha 1B-1 (GFP-N), aa 1768-2009 of alpha 1B-1 (GFP-NN), and aa 1768-1875 of alpha 1B-1 (GFP-NNN). These constructs are illustrated in Figure 5a. Note that the GFP-CCC1 construct corresponds to the region of alpha 1B-1 that differs from alpha 1B-2. Also note that the GFP-CC1 construct corresponds to the portion of alpha 1B-1 that was deleted in the Delta 1875-2339 construct.



View larger version (34K):
[in this window]
[in a new window]
 
Figure 5.   Immunoprecipitation experiments demonstrate Galpha q binding to the C terminus of alpha 1B. tsA-201 cells were co-transfected with various GFP fusion constructs and constitutively active rat Galpha q (Galpha q*). Immunoprecipitations were then performed as described in Materials and Methods. a, Graphical summary of the GFP fusion constructs used in this study. Portions of the C terminus of alpha 1B-1 and alpha 1B-2 were expressed as fusions with the GFP protein. Regions implicated in Gbeta gamma (Qin et al., 1997) and Galpha i/Galpha o (Furukawa et al., 1998a,b) binding are shown. b, An anti-rat Galpha q antibody that recognizes rat but not human Galpha q immunoprecipitated a GFP fusion of the C terminus of alpha 1B-1 (GFP-C1; lane 1) but not GFP alone (lane 2). No similar bands were immunoprecipitated in cells transfected with GFP-C1 but not Galpha q* (lane 3). An immunoprecipitation of GFP-C1 with an anti-GFP antibody from cells transfected with GFP-C1 alone is shown for size comparison (lane 4). c, Immunoprecipitations were also performed with an anti-GFP antibody. The anti-GFP antibody co-immunoprecipitated Galpha q* from cells expressing Galpha q* and GFP-C1 (lane 4) but not from cells expressing Galpha g* in the absence of GFP-C1 (lane 2). The anti-GFP antibody also co-immunoprecipitated Gbeta y from cells transfected with GFP-C1 as well as Gbeta y (lane 1). Co-expression of Galpha q* did not block Gbeta gamma association with the C terminus (lane 3). An immunoprecipitation of Gbeta with an anti-Gbeta antibody is shown for size comparison (lane 5). d, Immunoprecipitation of Galpha q in cells overexpressing Galpha q*, Gbeta gamma , and various GFP fusion molecules created from the C terminus of the alpha 1B channel. The construct NNN bound Galpha q*, suggesting that aa 1768-1875 of the channel are sufficient for Galpha q* binding.

As shown in Figure 5b, lane 1, a rat-specific anti-Galpha q antibody co-immunoprecipitated GFP-C1 in cells expressing rat Galpha q* and GFP-C1. Anti-Galpha q did not co-immunoprecipitate GFP in cells expressing Galpha q* and GFP (Fig. 5b, lane 2) and did not co-immunoprecipitate C1-GFP in cells that were not expressing rat Galpha q* (Fig. 5b, lane 3). As a molecular weight comparison, the GFP-C1 fragment was immunoprecipitated by an anti-GFP antibody (Fig. 5b, lane 4).

Similar results were obtained when immunoprecipitations were performed with an anti-GFP antibody (Fig. 5c). In cells expressing Galpha q*, Gbeta 1, Ggamma 3, and GFP-C1, an anti-GFP antibody immunoprecipitated Galpha q* as well as Gbeta gamma (Fig. 5c, lane 3). The antibody co-immunoprecipitated Gbeta gamma alone in cells expressing Gbeta gamma and GFP-C1 (Fig. 5c, lane 1) and Galpha q* alone in cells expressing Galpha q* and GFP-C1 (Fig. 5c, lane 4). Neither Galpha q* nor Gbeta gamma was immunoprecipitated in cells expressing Galpha q* and Gbeta gamma but no GFP-C1 (Fig. 5c, lane 2). Gbeta 1 was co-immunoprecipitated with an anti-Gbeta antibody for molecular weight comparison (Fig. 5c, lane 5).

To identify the region of the C terminus that interacts with Galpha q, various portions of the C terminus (see Fig. 5a) were expressed as GFP fusion molecules in tsA-201 cells along with rat Galpha q*, and cell lysates were subjected to immunoprecipitations with an anti-rat Galpha q antibody as well as an anti-GFP antibody for molecular weight determination. As shown in Figure 5d, The GFP-C2, GFP-NNN, GFP-NN, and GFP-N constructs co-immunoprecipitated with Galpha q*, but the GFP, GFP-CC1, GFP-CC2, and GFP-CCC1 constructs did not. These results suggest that Galpha q binds to the C terminus of alpha 1B-1 as well as alpha 1B-2 and that the N-terminal portion of the C terminus is sufficient for Galpha q binding. The interaction of Galpha q* with the C terminus of alpha 1B is similar to the findings of Furukawa et al. (1998a,b), who showed that Galpha i interacts with the C terminus of alpha 1B. This is the first demonstration that Galpha q binds to Ca channels. We were unable to directly assess the role of this portion of the C terminus by electrophysiology, because deletion (construct Delta 1768-2339) rendered the channel nonfunctional (data not shown).

Immunoprecipitation of Gbeta gamma in cells transfected with GFP-C1 and Gbeta 1gamma 3 confirms the findings of Qin et al. (1997) and Furukawa et al. (1998a,b), who showed that Gbeta gamma interacts with the C terminus of alpha 1B. Overexpression of Galpha q* failed to block the ability of an anti-GFP antibody to immunoprecipitate Gbeta gamma . These data suggest that although Galpha q and Gbeta gamma both bind to the C terminus of alpha 1B-1, displacement of Gbeta gamma binding to the C terminus by Galpha q is unlikely to be taking place. Our electrophysiology experiments suggest that truncation of the C terminus could block the ability of Galpha q to inhibit modulation, suggesting that regions not required for Galpha q binding are also involved in producing these effects.

The role of PKC

Binding of Galpha q to the N-terminal portion of the C terminus (aa 1768-1875) suggests that Galpha q is probably not directly involved in the differential translocation of the C terminus of alpha 1B-1 and alpha 1B-2 in our imaging experiments or the differential susceptibility of the two channels to modulation by GalR2. However, our overexpression studies clearly suggest that Galpha q is capable of occluding modulation and that this effect of Galpha q is lost when regions C-terminal to this Galpha q binding site are disrupted. Galpha q may therefore exert its effects indirectly. Because Galpha q-coupled receptors can activate PKC, and PKC can block Gbeta gamma effects by phosphorylation of Thr-422 on the I/II loop of the channel (Hamid et al., 1999), we tested the hypothesis that PKC activation by GalR2 was involved in blocking Gbeta gamma effects. When HEK-293 cells expressing alpha 1B-1 and GalR2 were exposed to galanin and the PKC inhibitor staurosporine (1 µM) simultaneously, marked voltage-dependent inhibition was observed (Fig. 6a). Currents were inhibited by 49.3 ± 8.3% (n = 12), in contrast to the lack of inhibition observed in the absence of staurosporine (Fig. 1d). Currents after a prepulse were inhibited by 21.7 ± 1.9% (n = 12), significantly less than the inhibition observed before a prepulse (p < 0.05). These results suggest that the inhibition seen in the presence of staurosporine is substantially but not completely voltage-dependent.



View larger version (41K):
[in this window]
[in a new window]
 
Figure 6.   Involvement of PKC. a, HEK-293 cells were transfected with GalR2, alpha 1B-1, beta 1b, alpha 2/delta , and CD8alpha . Galanin (100 nM) was applied simultaneously with staurosporine (1 µM) at the times indicated. In contrast to observations in the absence of staurosporine, staurosporine and galanin caused marked current inhibition. b, HEK-293 cells were transfected with GalR2, alpha 1B-1, beta 1b, alpha 2/delta , CD8alpha , and cDNA for a kinase-inactive PKC-delta [HA-PKC-delta -kinase dead (Kd)]. Expression of HA-PKC-delta -kd was verified by immunostaining (data not shown). When galanin (100 nM) was applied, marked current inhibition was observed. c, tSA-201 cells were transfected with GalR2, C1-GFP, and HA-PKC-delta . In the absence of galanin, C1-GFP and HA-PKC delta  were found evenly distributed throughout the cytoplasm (top panel). After exposure to galanin, both proteins translocated to the plasma membrane (bottom panel).

A number of groups have demonstrated that phorbol esters can increase Ca currents and reduce G-protein modulation of Ca channels (Zhu and Ikeda, 1994; Stea et al., 1995; Hamid et al., 1999). Stea et al. (1995) observed that staurosporine applied at 5-10 µM blocked the effects of phorbol esters and metabotropic glutamate receptor activation on Ca currents. PKC-delta , a novel-type PKC, has been shown by a number of groups to be activated by Gq-coupled receptors. For example, PKC-delta has been implicated in the actions of alpha 1-adrenergic receptors (Rohde et al., 2000), AT1-type angiotensin receptors (Muscella et al., 2000), and purinergic receptors (Shirai et al., 2000). When HEK-293 cells were transfected with a kinase-inactive PKC-delta , alpha 1B-1, and GalR2, galanin was observed to cause voltage-dependent inhibition of the currents. Galanin caused 31.6 ± 6.6% (n = 5) inhibition of currents before a prepulse and 17.6 ± 6.2% inhibition of currents after a prepulse, suggesting that the inhibition was substantially but not completely voltage-dependent and somewhat lower in magnitude than the inhibition observed in the presence of staurosporine (Fig. 6b).

To further confirm the involvement of PKC, tsA-201 cells were transfected with GalR2, C1-GFP, and a hemaglutinin (HA) tagged PKC-delta (HA-PKC delta ). In the absence of galanin, C1-GFP and HA-PKC delta  were seen to be distributed throughout the cytoplasm. When cells were exposed to galanin, both molecules translocated and were co-localized at the cell surface (Fig. 6c). These results are consistent with the notion that the C terminus of alpha 1B-1 associates with PKC, possibly through a modular adapter protein (Jaken and Parker, 2000), and associates with the membrane through such an interaction. These experiments suggest that PKC-delta is involved, but we cannot exclude the involvement of other PKC isoforms on the basis of these experiments.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The experiments reported here seek to determine why activation of Galpha q-coupled GPCRs fails to produce voltage-dependent inhibition of N-type Ca channels. The results suggest that the Galpha subunit linked to such receptors may play an essential role in producing this selectivity and that the C terminus of the channel plays an important role in mediating these effects. Although Galpha q binds to the proximal (N-terminal) portion of the C terminus, we also observed evidence for a functional role of the distal end of the C terminus in our electrophysiological and imaging experiments. Although this region of the channel appeared not to be necessary for binding Galpha q, both the electrophysiological and imaging data suggest that it plays some role in mediating the effects of Galpha q.

Perhaps the most compelling model to account for our results is a model in which Galpha q that is associated with the proximal portion of the C terminus of the channel locally activates PKC, which in turn phosphorylates the channel and blocks Gbeta gamma -mediated inhibition (Fig. 7). PKC may indirectly associate with the distal portion of the C terminus of the channel, possibly through modular PDZ domain-containing adapter proteins (Jaken and Parker, 2000